John Markels - 08 Dec 2022 Form 4 Insider Report for Arcturus Therapeutics Holdings Inc. (ARCT)

Role
Director
Signature
/s/ Grant Levine, as attorney-in-fact for Dr. John Markels
Issuer symbol
ARCT
Transactions as of
08 Dec 2022
Net transactions value
$0
Form type
4
Filing time
13 Dec 2022, 15:10:36 UTC
Previous filing
06 Jun 2022
Next filing
05 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARCT Stock option (right to buy) Award $0 +20,000 $0.000000 20,000 08 Dec 2022 Common Stock 20,000 $18.04 Direct F1
transaction ARCT Stock option (right to buy) Award $0 +6,986 $0.000000 6,986 08 Dec 2022 Common Stock 6,986 $18.04 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares underlying the option vest monthly over a two year period from the date of grant. This represents the initial grant to the Reporting Person as a member of the Board of Directors (the "Board").
F2 Shares underlying the option vest monthly over a one year period from the date of grant. This represents the annual grant to the Reporting Person as a member of the Board, prorated based on the date the Reporting Person was appointed to the Board, representing an estimated six months of service.